Results 31 to 40 of about 1,185,879 (186)
Immunohistochemistry as a tool for identifying PDGFRA amplification in central nervous system tumors. [PDF]
PDGFRA gene amplification is now recognized as a diagnostically and prognostically relevant molecular alteration in central nervous system tumors. Herein, we demonstrated that PDGFRA immunohistochemistry is a highly specific and sensitive biomarker for identifying PDGFRA amplification and should be part of the neuropathologist's routine panel of ...
Tauziède-Espariat A +5 more
europepmc +2 more sources
Tumor-type-specific expression of TTF-1 in primary central nervous system tumors classified by the 2021 WHO criteria. [PDF]
Abstract Thyroid transcription factor‐1 (TTF‐1) is a widely used immunohistochemical marker for tumors of thyroid and pulmonary origin; however, its expression profile and diagnostic relevance in primary central nervous system (CNS) tumors remain incompletely characterized, particularly following the revisions in the 2021 WHO Classification of CNS ...
Xu L +8 more
europepmc +2 more sources
Dysembryoplastic neuroepithelial tumor of cerebellum in a child [PDF]
Disembriyoplastik nöroepitelyial tümörler (DNT) tipik olarak supratentorial yerleşen benign neoplazmalardır. Bilinç ve postural tonus kaybı şikayetleri ile bir lokal hastaneye başvuran 12 yaşındaki erkek hasta saptanan serebellar kitlesi nedeniyle ...
Paksoy, Yahya +5 more
core +2 more sources
O tumor disembrioplástico neuroepitelial (TDN) é entidade tumoral relativamente nova que foi descrita pela primeira vez por Daumas-Duport et al. em 1988 e foi incorporado à classificação de tumores cerebrais da Organização Mundial da Saúde em 1993.
Luiz Fernando Bleggi Torres +3 more
doaj +1 more source
DNET presenting with bleed: An infrequent event – Histopatho-radio-surgical report
Dysembryoplastic neuroepithelial tumors (DNET) are Grade 1 tumors and second most common cause of drug resistant tumor associated epilepsy in young population.
Simranjeet Singh +4 more
doaj +1 more source
Background: Myxoid glioneuronal tumor (MGT) is a benign glioneuronal neoplasm recently introduced in the World Health Organization (WHO) classification of the central nervous system (CNS) tumors.
C. Caporalini +12 more
doaj +1 more source
Pediatric intracerebral anaplastic ganglioglioma : A Case Report
Anaplastic ganglioglioma (AGG) is an extremely rare aggressive, epileptogenic braintumor. It is considered to be WHO grade III variant of ganglioglioma. Due to non-specific clinical manifestations and radiographic features, preoperative diagnosis of AGG ...
Dipendra Kumar Shrestha +3 more
doaj +1 more source
Non-invasive therapeutic brain stimulation for treatment of resistant focal epilepsy in a teenager
Aims: A 13-year-old boy with symptomatic focal epilepsy due to a right parietal dysembryoplastic neuroepithelial tumor (DNET) presented pre- and post-operatively fluctuating tinnitus and sensory symptoms which became persistent after incomplete tumor ...
Miguel Muñoz-Ruiz +3 more
doaj +1 more source
Dysembryoplastic neuroepithelial tumour: insight into the pathology and pathogenesis
Dysembryoplastic neuroepithelial tumour (DNT) is categorized as a benign glioneuronal neoplasm affecting children and young adults with chronic epileptic seizures.
Wieslawa Grajkowska +3 more
core +1 more source
SEIZURES IN CHILDREN WITH LOW GRADE GLIOMA
Seizures are a common presentation of pediatric brain tumors. The incidence of pediatric brain tumor (Age 0-19 years) ranges from 1.12–5.26 cases per 100,000 persons. Low grade gliomas are an important subgroup of pediatric brain tumors causing epilepsy.
Piyush Ostwal, Shanbhag Nandan
doaj +1 more source

